Journal article

Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction

Owen L Woodman, Wachirawadee Malakul, Anh H Cao, Qi Xu, Rebecca H Ritchie

LIFE SCIENCES | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2008

Abstract

Atrial natriuretic peptide (ANP) exerts beneficial effects on the cardiovascular system in part by exerting antioxidant activity. Given that oxidant stress is a key cause of endothelial dysfunction in diabetes, we investigated whether ANP improves endothelial function in rats with diabetes. Rats were injected with streptozotocin (55 mg/kg iv) to induce type 1 diabetes or the citrate vehicle as controls (n=12). After 4 weeks the diabetic rats were treated with ANP (10 pmol/kg/min sc, n=12) or the antioxidant tempol (1.5 mmol/kg/day sc, n=11), both by osmotic minipump, ramipril (1 mg/kg per day in the drinking water) or remained untreated (n=11). After a further 4 weeks, anaesthetised rats wer..

View full abstract